Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ODE Adding Third Deputy Director; Feigal Outlines CDRH Ombudsman Role

This article was originally published in The Gray Sheet

Executive Summary

The Center for Devices and Radiological Health's next Office of Device Evaluation Director will possess a medical degree, CDRH Director David Feigal said in a Nov. 9 interview with "The Gray Sheet."
Advertisement

Related Content

FDA Veteran Schultz Ascends To CDRH Director Position: Who Will Lead ODE?
FDA Veteran Schultz Ascends To CDRH Director Position: Who Will Lead ODE?
MDUFMA Resource Management Is Schultz’s First Aim As Acting CDRH Chief
MDUFMA Resource Management Is Schultz’s First Aim As Acting CDRH Chief
Radiology Review Division Chief Moves Up To ODE Deputy Director Post
CDRH staff changes
CDRH Director To Serve As Acting ODE Director; Alpert Joins FDA Food Center
CDRH Director To Serve As Acting ODE Director; Alpert Joins FDA Food Center
Dispute Resolution Guidance Flouts FDAMA And Favors CDRH, HIMA Says
CDRH Dispute Resolution Guidance Spells Out Panel Membership, Timeframes
Advertisement
UsernamePublicRestriction

Register

MT012578

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel